FTRE Fortrea Holdings Inc.
Company Analysis
Latest News
🟢 Fortrea Holdings is trading 4.1% up today amid healthcare-sector gains
Fortrea Holdings is trading at $23.71, up 4.10%, with the move appearing sector-led amid healthcare gains. - Healthcare was up 2.12%, amid rotation from...
🟢 Fortrea Holdings rises 4.0% — Healthcare Stocks Surge on Sector Rotation Out of Tech
With Healthcare (XLV) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector is experiencing a significant...
🟢 Fortrea Holdings is trading 5% up today after Deutsche Bank upgraded it to Buy
Fortrea Holdings is trading 5.46% up at $22.50, with Deutsche Bank’s October 15 upgrade from Hold to Buy providing the clearest company-specific catalyst. -...
🟢 Fortrea Holdings is trading 5% up in pre-market after Deutsche Bank upgraded Fortrea to Buy
Fortrea Holdings is trading at $22.47, up 5.30% in pre-market on October 15, after Deutsche Bank upgraded it from Hold to Buy and raised its price target from...
Barclays Bets Fortrea's Turnaround Is Real — But Can a $2 Billion Company Grow Into Its New Optimism?
Shares of Fortrea Holdings surged 10.8% to $23.39 after Barclays analyst Luke Sergott upgraded the contract research organization — a company that runs...
🟢 Fortrea Holdings is trading 11% up today after Barclays upgraded it to Overweight
Fortrea Holdings is trading at $23.39, up 10.82%, after a company-specific Barclays upgrade to Overweight from Equalweight. - Barclays raised its price target...
🟢 Fortrea Holdings is trading 6.4% up; no clear company-specific catalyst
Fortrea Holdings is trading 6.44% higher at $22.47, with no clear company-specific catalyst identified. - On October 6, 2026, broader markets were also...
🟢 Fortrea Holdings is trading 5% up with no clear company-specific catalyst identified
On October 5, 2026, Fortrea Holdings is trading 5.18% up at $21.04, with no clear company-specific catalyst identified. - Fortrea announced it will report...
🔴 Fortrea Holdings is trading 7% down in pre-market with no clear catalyst identified
Fortrea Holdings is trading at $18.55 (-7.02%) in pre-market on October 1, with no clear catalyst identified. - No confirmed October 1 company announcement...
Fortrea Discloses DOJ Inquiry Into Clinical Trial Data Integrity
Fortrea Holdings Inc. disclosed in an SEC filing today that it received a Civil Investigative Demand from the U.S. Department of Justice. The inquiry concerns...
🟢 Fortrea Holdings is trading 5.31% up today amid broad risk-on recovery
Fortrea Holdings is trading 5.31% up now at $21.07, alongside a broad September 17, 2026 risk-on recovery. - The S&P 500, Nasdaq Composite, and Dow Jones...
🟢 Fortrea Holdings is trading 10.1% up today as healthcare gains 1.28%
Fortrea Holdings is trading at $19.17, up 10.11%, outperforming as healthcare gains 1.28% and investors favor defensive sectors while broader markets...
🟢 Fortrea Holdings is trading 5% up today amid defensive healthcare positioning
Fortrea Holdings is trading at $18.31 (+5.17%) as healthcare stocks outperform while investors seek defensive positioning amid market volatility. - Fortrea is...
Fortrea Reinstates Jason Knoblauch as Chief Financial Officer Following Lawsuit Settlement
Fortrea Holdings Inc. has reinstated Jason Knoblauch as its Chief Financial Officer, effective September 9, 2026. This follows the resolution of a lawsuit with...
🔴 Fortrea Holdings is trading 5% down today amid reduced rate-cut expectations
Fortrea Holdings is trading 5.05% down now at $17.68, with stronger employment data and reduced rate-cut expectations potentially contributing to broader...
🟢 Fortrea Holdings is trading 5% up today after announcing $45 million Worldwide Clinical Trials acquisition
Fortrea Holdings is trading 5.16% up now at $18.64 after announcing on September 2, 2026, a definitive agreement to acquire Worldwide Clinical Trials’ Early...
🟢 Fortrea Holdings is trading 5.6% up in after-hours trading
Fortrea Holdings is trading 5.6% up at $19.22 after no clearly confirmed company-specific announcement was identified for August 20, 2026. - COO Mark Morais...